GIGYF1 Gene

GIGYF1 Gene

Introduction

Gigyf1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@bassil2020]
<table> [@liu2014]
<tr><th colspan="2">GIGYF1 Gene</th></tr> [@zheng2012]
<tr><td>Gene Symbol</td><td>GIGYF1</td></tr> [@klein2021]
<tr><td>Full Name</td><td>GRB10 Interacting GYF Protein 1</td></tr> [@simon2022]
<tr><td>Chromosomal Location</td><td>7p12.1</td></tr> [@tolosa2023]
<tr><td>NCBI Gene ID</td><td>[98668](https://www.ncbi.nlm.nih.gov/gene/98668)</td></tr> [@poewe2021]
<tr><td>OMIM</td><td>607996</td></tr>
<tr><td>Ensembl ID</td><td>ENSG00000146830</td></tr>
<tr><td>UniProt</td><td>[Q9UGN0](https://www.uniprot.org/uniprot/Q9UGN0)</td></tr>
<tr><td>Associated Diseases</td><td>Parkinson's Disease</td></tr>
</table>
</div>

Overview

GIGYF1 (GRB10 Interacting GYF Protein 1) encodes a protein that interacts with the growth factor receptor-bound protein 10 (GRB10) and is involved in insulin-like growth factor (IGF) signaling. Genome-wide association studies (GWAS) have identified GIGYF1 variants as risk factors for Parkinson's disease, suggesting a role in IGF signaling and neuronal survival[1].

Gene Structure

The GIGYF1 gene contains:

• Exons: Multiple coding exons
• Alternative Splicing: Produces multiple transcript variants
• Promoter: Contains regulatory elements

Normal Function

GIGYF1 participates in signaling pathways:

GIGYF1 Gene

Introduction

Gigyf1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@bassil2020]
<table> [@liu2014]
<tr><th colspan="2">GIGYF1 Gene</th></tr> [@zheng2012]
<tr><td>Gene Symbol</td><td>GIGYF1</td></tr> [@klein2021]
<tr><td>Full Name</td><td>GRB10 Interacting GYF Protein 1</td></tr> [@simon2022]
<tr><td>Chromosomal Location</td><td>7p12.1</td></tr> [@tolosa2023]
<tr><td>NCBI Gene ID</td><td>[98668](https://www.ncbi.nlm.nih.gov/gene/98668)</td></tr> [@poewe2021]
<tr><td>OMIM</td><td>607996</td></tr>
<tr><td>Ensembl ID</td><td>ENSG00000146830</td></tr>
<tr><td>UniProt</td><td>[Q9UGN0](https://www.uniprot.org/uniprot/Q9UGN0)</td></tr>
<tr><td>Associated Diseases</td><td>Parkinson's Disease</td></tr>
</table>
</div>

Overview

GIGYF1 (GRB10 Interacting GYF Protein 1) encodes a protein that interacts with the growth factor receptor-bound protein 10 (GRB10) and is involved in insulin-like growth factor (IGF) signaling. Genome-wide association studies (GWAS) have identified GIGYF1 variants as risk factors for Parkinson's disease, suggesting a role in IGF signaling and neuronal survival[1].

Gene Structure

The GIGYF1 gene contains:

• Exons: Multiple coding exons
• Alternative Splicing: Produces multiple transcript variants
• Promoter: Contains regulatory elements

Normal Function

GIGYF1 participates in signaling pathways:

Molecular Mechanism

GIGYF1 functions through:

Protein Domain Structure

The GIGYF1 protein contains several functional domains:

• GYF Domain: Proline-rich binding motif that mediates protein-protein interactions
• coiled-coil regions: Facilitate dimerization and complex formation
• N-terminal Domain: Involved in subcellular localization

Signaling Pathway Interactions

GIGYF1 modulates multiple signaling cascades:

• AKT phosphorylation status affects neuronal viability
• Modulates mTORC1 activity and [autophagy](/entities/autophagy)

• Affects CREB activation and gene expression
• Regulates synaptic plasticity

• GIGYF1 variants may reduce neuroprotective signaling
• Impacts mitochondrial function in dopaminergic [neurons](/entities/neurons)

Post-Translational Modifications

GIGYF1 undergoes various PTMs:

• Phosphorylation: Multiple serine/threonine sites identified
• Ubiquitination: Targets protein for degradation
• Sumoylation: Affects nuclear-cytoplasmic shuttling

Brain Region Distribution

GIGYF1 is expressed in:

• [Cortex](/brain-regions/cortex)
• [Hippocampus](/brain-regions/hippocampus)
• Basal ganglia
• Cerebellum
• Spinal cord

Disease Associations

Parkinson's Disease

GIGYF1 is a risk gene for PD:

• GWAS Associations: Multiple studies implicate GIGYF1 variants
• IGF Signaling: Altered neuroprotective IGF signaling
• Neuronal Survival: May affect dopaminergic neuron viability
• Mechanism: Reduced IGF1-mediated neuroprotection[2]

Other Neurological Conditions

• Alzheimer's Disease: IGF signaling alterations
• Diabetes-associated neurodegeneration: Shared mechanisms

Therapeutic Targeting

Strategies targeting GIGYF1 pathways:

Current Therapeutic Approaches

IGF-Based Therapies

• IGF-1: Recombinant protein for neuroprotection
• IGF-1 Mimetics: Small molecules mimicking IGF-1 activity
• Delivery Methods: Intranasal, subcutaneous, and viral vector approaches

GRB10 Modulation

• GRB10 Antagonists: Block inhibitory interactions
• Peptide Mimetics: Designed to disrupt GIGYF1-GRB10 binding
• Allosteric Modulators: Target protein-protein interaction interfaces

Downstream Pathway Activators

• AKT Activators: Direct AKT phosphorylation enhancers
• [mTOR](/entities/mtor) Modulators: Rapamycin and analogues for autophagy induction
• Neurotrophic Factors: BDNF and GDNF delivery approaches

Clinical Considerations

| Approach | Advantages | Challenges | Status |
|----------|-----------|------------|--------|
| IGF-1 Intranasal | Non-invasive, direct CNS delivery | Short half-life | Phase II |
| AAV-GDNF | Long-term expression | Surgical delivery | Preclinical |
| Small Molecule AKT Activators | Oral bioavailability | Specificity concerns | Phase I |

Research Directions

Key research priorities:

• Understanding GIGYF1 variant effects on protein function
• Developing IGF-targeted therapies
• Biomarkers for IGF pathway activity
• Link between metabolism and neurodegeneration

Background

The study of Gigyf1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Allen Brain Atlas Resources

• Allen Human Brain Atlas: [GIGYF1 gene expression](https://human.brain-map.org/microarray/search/show?search_term=GIGYF1)
• Allen Mouse Brain Atlas: [GIGYF1 expression](https://mouse.brain-map.org/search/index.html?query=GIGYF1)
• Allen Cell Type Atlas: [Transcriptomic cell type reference](https://portal.brain-map.org/atlases-and-data/rnaseq)
• BrainSpan Atlas: [GIGYF1 developmental expression](https://www.brainspan.org/rnaseq/search/index.html?search_term=GIGYF1)

See Also

• [Parkinson's Disease](/diseases/parkinsons-disease)
• IGF Signaling Pathway
• [Dopaminergic Neurons](/cell-types/dopaminergic-neurons)
• [Neuroprotection](/mechanisms/neuroprotection)
• [Alpha-Synuclein Pathway](/proteins/alpha-synuclein)
• [Mitochondrial Dysfunction Pathway](/mechanisms/mitochondrial-dysfunction)
• [Neuroinflammation Pathway](/mechanisms/neuroinflammation-pathway)
• [LRRK2 Gene](/genes/lrrk2)
• GBA Gene